Edelfosine in membrane environment - the Langmuir monolayer studies

Anti-Cancer Agents in Medicinal Chemistry

Volumn 14, Issue 4, 2014, Pages 499-508

  Dynarowicz Łatka, Patrycja ^a   Hac Wydro, Katarzyna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Edelfosine; Interactions; Langmuir monolayers; Model lipids membranes

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL; EDELFOSINE; GANGLIOSIDE; MEMBRANE LIPID; SPHINGOMYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANTINEOPLASTIC ACTIVITY; ATOMIC FORCE MICROSCOPY; BREWSTER ANGLE MICROSCOPY; CARCINOGENICITY; CELL MEMBRANE; COMPRESSION; LANGMUIR MONOLAYER TECHNIQUE; MEMBRANE BIOLOGY; MEMBRANE FLUIDITY; POLYMERIZATION; PROTEIN LIPID INTERACTION; REVIEW; SURFACE PROPERTY; X RAY DIFFRACTION;

ANTINEOPLASTIC AGENTS; CHOLESTEROL; GANGLIOSIDES; HUMANS; MEMBRANE FLUIDITY; MEMBRANE MICRODOMAINS; NEOPLASMS; PHOSPHOLIPID ETHERS; SPHINGOMYELINS; UNILAMELLAR LIPOSOMES;

EID: 84907468420     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520614666140309230722     Document Type: Review

References (83)

1. Aveyard, R.; Haidon, R. An introduction to the principles of surface chemistry. Cambrigde University Press: London, 1973.
2. Adamson, A.W. Physical chemistry of surfaces, 3rd ed.; Wiley & Sons: New York, 1976.
3. Hiemenz, P. Principles of colloid and surface chemistry, 2nd ed.; Marcel Dekker, Inc.: New York, 1986.
4. Gaines Jr., G.L. Insoluble monolayers at liquid-gas interfaces. Interscience, New York: 1966.
5. Dynarowicz-Łatka, P.; Kita, K.; Milart, P.; Dhanabalan, A.; Cavalli, A.; Da Silva Filho, D.A.; Oliveira Jr. O.N. Structural modification influences the characteristics of Langmuir monolayers from aromatic carboxylic acids. J. Colloid Interf. Sci., 2001, 239, 158-167.
6. Karp, G. Cell and molecular biology: concepts and experiments, 4th ed.; Wiley & Sons: New York, 2004.
7. Chapman, D. Ed; Biological membranes - physical fact and function. Academic Press: London and New York, 1968.
8. Seydel, J.K.; Wiese, M. Drug-membrane interactions. Ed. Mannhold, R.; Kubinyi, H.; Folkers, G. Wiley-VCH, Verlag GmbH, Weinheim, 2002.
9. Maget-Dana, R. The monolayer technique: A potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim. Biophys. Acta, 1999, 1462, 109-140.
10. Hac-Wydro, K.; Dynarowicz-Łatka, P. Biomedical applications of the Langmuir monolayer technique. Annales UMCS, Ser. AA (Chemia), 2008, 63, 47-60.
11. Peetla, C.; Stine, A.; Labhasetwar, V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol. Pharmaceut., 2009, 6, 1264-1276.
12. Chan, Y-H.M.; Boxer, S.G. Model membrane systems and their applications. Curr. Opin. Chem. Biol., 2007, 11, 581-587.
13. Kell, D.B. Are liposomes good models for biomembranes?. Trends Biochem. Sci., 1981, 6, 8-9.
14. Ottova, A.L.; Tien, T.H. Self-assembled bilayer lipid membranes: from mimicking biomembranes to practical applications. Bioelectrochem. Bioenergetic, 1997, 42, 141-152.
15. Richter, R.P.; Berat, R.; Brisson, A.R. Formation of solid-supported lipid bilayers: An integrated view. Langmuir, 2006, 22, 3497-3505.
16. Brockman, H. Langmuir monolayers - why use half of membrane to characterize protein-membrane interactions. Curr. Opin. Struc. Biol, 1999, 9, 438-443.
17. Miñones, A., Jr., Pais, S.; Miñones, J.; Conde, O.; Dynarowicz-Latka, P. Interactions between membrane sterols and phospholipids in model mammalian and fungi cellular membranes - A Langmuir monolayer study. Biophys. Chem., 2009, 140, 69-77.
18. Hac-Wydro, K.; Kapusta, J.; Jagoda, A.; Wydro, P.; Dynarowicz-Latka, P. The influence of phospholipid structure on the interactions with nystatin, a polyene antifungal antibiotic A Langmuir monolayer study. Chem. Phys. Lipids 2007, 150, 125-135.
19. Jabłonowska, E.; Bilewicz, R. Interactions of ibuprofen with Langmuir monolayers of membrane lipids. Thin Solid Films, 2007, 515, 3962-3966.
20. Borissevitch, G.P.; Tabak, M.; Oliveira, O.N. Interaction of dipyridamole with lipids in mixed Langmuir monolayers. Biochim. Biophys. Acta, 1996, 1278, 12-18.
21. Gomez-Serranillos, I.R.; Miñones, J., Jr.; Dynarowicz-Latka, P.; Miñones, J.; Conde, O. Surface behavior of oleoyl palmitoyl phosphatidyl ethanolamine (OPPE) and the characteristics of mixed OPPE-Miltefosine monolayers. Langmuir, 2004, 20, 11414-11421.
22. Rakotomanga, M.; Loiseau, P.M.; Saint-Pierre-Chazalet, M. Hexadecylphosphocholine interaction with lipid monolayers. Biochim. Biophys. Acta, 2004, 1661, 212-218.
23. Dynarowicz-Latka, P.; Dhabanalan, A.; Oliveira, O.N. Jr. Modern physicochemical research on langmuir monolayer. Adv. Coll. Interf. Sci., 2001, 91, 221-293.
24. Feng, S.S. Interpretation of mechanochemical properties of lipid bilayer vesicles from the equation of state or pressure-area measurement of the monolayer at the air-water or oil-water interface. Langmuir, 1999, 15, 998-1010.
25. Davies, J.T.; Rideal, E.K. Interfacial Phenomena. Academic Press, New York. 1963
26. Dynarowicz-Latka, P.; Kita, K. Molecular interaction in mixed monolayers at the air/water interface. Adv. Coll. Interf. Sci., 1999, 79, 1-17.
27. Gong, K.; Feng, S.S.; Go, M.L.; Soew, P.H. Effects of pH on the stability and compressibility of DPPC/cholesterol monolayers at the air/water interface. Colloids Surf. A, 2002, 207, 113-125.
28. Miñones, J., Jr.; Miñones, J.; Conde, O.; Rodriguez Patino, J.M.; Dynarowicz-Latka, P. Mixed monolayers of Amphotericin B-dipalmitoyl phosphatidyl choline: Study of complex formation. Langmuir, 2002, 18, 2817-2827.
29. De Lima, V.R.; Caro, M.S.B.; Munford, M.L.; Desbat, B.; Dufourc, E.; Pasa, A.A.; Creczynski-Pasa, T.B. Influence of melatonin on the order of phosphatidylcholine-based membranes. J. Pineal Res., 2010, 49, 169-175.
30. Azouzi, S.; El Kirat, K.; Morandat, S. The potent antimalarial drug Cyclosporin A preferentially destabilizes sphingomyelin-rich membranes. Langmuir, 2010, 26(3), 1960-1965.
31. Santos, N.C.; Ter-Ovanesyan, E.; Zasadzinski, J.A.; Prieto, M.; Castanho, M.A.R.B. Filipin-induced lesions in planar phospholipid bilayers imaged by atomic force microscopy. Biophys. J., 1998, 75, 1869-1873.
32. Herculano, R.D.; Pavinatto, F.J.; Caseli, L.; D'Silva, C; Oliveira, O.N., Jr. The lipid composition of a cell membrane modulates the interaction of an antiparasitic peptide at the air-water interface. Biochim. Biophys. Acta, 2011, 1808, 1907-1912.
33. Pavinatto, F.J.; Pacholatti, C.P.; Montanha, E.A.; Caseli, L.; Silva, H.S.; Miranda, P.B.; Viitala, T.; Oliveira, O.N., Jr. Cholesterol mediates chitosan activity on phospholipid monolayers and Langmuir-Blodgett films. Langmuir, 2009, 25(17), 10051-10061.
34. Maldonado-Valderrama, J.; Wege, H.A.; Rodriguez-Valverde, M.A.; Galvez-Ruiz, M.J.; Cabrerizo-Vilchez, M.A. Comparative study of adsorbed and spread /?-casein monolayers at the water-air interface with the pendant drop technique. Langmuir, 2003, 19, 8436-8442.
35. Schmidt, T.F.; Caseli, L.; Nobre, T.M.; Zaniquelli, M.E.D.; Oliveira, O.N., Jr. Interaction of horseradish peroxidase with Langmuir monolayers of phospholipids. Coll. Surf. A., 2008, 321, 206-210.
36. Haas, H.; Caetano, W.; Borissevitch, G.P.; Tabak, M.; Mosquera Sanchez, M.I.; Oliveira, O.N., Jr.; Scalas, E.; Goldmann, M. Interaction of dipyridamole with phospholipid monolayers at the air/water interface: Surface pressure and grazing incidence X-ray diffraction studies. Chem. Phys. Lett., 2001, 335, 510-516.
37. Jablin, M.J.; Flasihski, M.; Dubey, M.; Ratnaweera, D.R.; Broniatowski, M.; Dynarowicz-Latka, P.; Majewski, J. Effects of p-cyclodextrin on the structure of sphingomyelin/cholesterol model membranes. Biophys. J., 2010, 99, 1475-1481.
38. Hac-Wydro, K.; Dynarowicz-Latka, P.; Grzybowska, J.; Borowski, E. Interactions of amphotericin B derivative of low toxicity with biological membrane components - The Langmuir monolayer approach. Biophys. Chem., 2005, 116, 77-88.
39. Seoane, R.; Miñones, J.; Conde, O.; Casas, M.; Iribarnegaray, E. Molecular organization of amphotericin B at the air-water interface in the presence of sterols: a monolayer study. Biochim. Biophys. Acta, 1998, 1375(1-2), 73-83.
40. Hac-Wydro, K.; Dynarowicz-Latka, P. Interaction between nystatin and natural membrane lipids in Langmuir monolayers - The role of phospholipids in the mechanism of polyene action. Biophys. Chem., 2006, 123, 154-161.
41. Schnoller, D.; Penzes, C.B.; Horvati, K.; Bosze, Sz.; Hudecz, F.; Kiss, E. Membrane affinity of new antitubercular drug candidates using phospholipid Langmuir monolayer model and LB technique. Prog. Colloid Polym. Sci., 2011, 138, 131-137.
42. Sujak, A.; Gruszecki, W.I. Organization of mixed monomolecular layers formed with the xanthophylls pigments lutein or zeaxanthin and dipalmitoylphosphatidylcholine at the argon-water interface. J. Photochem. Photobiol. B., 2000, 59, 42-47.
43. Gajate, C; Mollinedo, F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipids ET-18-OCH3 (Edelfosine), A proapoptotic agent in tumor cells. Curr. Drug Metab., 2002, 3, 491-525.
44. Arthur, G.; Bittman, R. The inhibition of cell signaling pathways by antitumor ether lipids. Biochim. Biophys. Acta, 1988, 1390, 85-102.
45. Busto, J.V.; Sot, J.; Goni, F.M.; Mollinedo, F.; Alonso, A. Surface active properties of the antitumor lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine). Biochim. Biophys. Acta, 2007, 1768, 1855-1860.
46. Osak, A.; Dynarowicz-Latka, P.; Conde, O.; Miñones Jr, J.; Pais, S. Edelfosine - a new antineoplastic drug based on a phospholipid-like structure. The Langmuir monolayer study. Colloids Surf., A, 2008, 319, 71-76.
47. Miñones, J.; Patino, J.M.R.; Conde, O.; Carrera, C; Seoane, R. The effect of polar groups on structural characteristics of phospholipids monolayers spread at the air-water interface. Colloids Surf. A, 2002, 203, 273-286.
48. Hac-Wydro, K.; Dynarowicz-Latka, P. The impact of sterol structure on the interactions with sphingomyelin in mixed Langmuir monolayers. J. Phys. Chem. B, 2008, 112(36), 11324-11332.
49. Hendrich, A.B.; Michalak, K. Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr. Drug Targets, 2003, 4, 23-30.
50. Perkins, W.R.; Dause, R.B.; Li, X.; Franklin, J.C.; Cabrall-Lilly, D.J.; Zha, Y.; Dank, E.H.; Mayhew, E.; Janoff, A.S. Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity. Biochim. Biophys. Acta, 1997, 1327, 61-68.
51. Wiecek, A.; Dynarowicz-Latka, P.; Miñones, J. Jr.; Conde, O.; Casas, M. Interactions between an anticancer drug - edelfosine -and cholesterol in Langmuir monolayers. Thin Solid Films, 2008, 516, 8829-8833.
52. Wiecek, A.; Dynarowicz-Latka, P.; Vila-Romeu, N.; Nieto-Suarez, M.; Flasihski, M. Interactions between an anticancer drug -edelfosine- and DPPC in Langmuir monolayers. Colloids Surf., A, 2008, 321, 201-205.
53. Hac-Wydro, K.; Flasihski, M.; Wydro, P.; Dynarowicz-Latka, P. Towards the understanding of the behavior of single-chained ether phospholipids in model biomembranes. Interactions with phosphatidylethanolamines in Langmuir monolayers. Coll. Surf., B, 2012, 97, 162-170.
54. Hac-Wydro, K.; Dynarowicz-Latka, P. Searching for the role of membrane sphingolipids in selectivity of antitumor ether lipid-edelfosine. Colloids Surf. B, 2010, 81, 492-497.
55. Flasihski, M.; Hac-Wydro, K.; Wydro, P.; Broniatowski, M.; Dynarowicz-Latka, P. Interactions between single-chained ether phospholipids and sphingomyelin in mixed monolayers at the air/water interface - Grazing Incidence X-ray Diffraction and Brewster Angle Microscopy studies. Coll. Surf. B, 2013, 111, 43-51.
56. Busto, J.V.; Del Canto-Janes, E.; Goni, F.M.; Mollinedo, F.; Alonso, A. Combination of the anti-tumour cell ether lipid edelfosine with sterols abolishes haemolytic side effects of the drug. J. Chem. Biol., 2008, 1, 89-94.
57. Israelachvili, J.N. Intermolecular and Surface Forces. Academic Press, New York. 2011.
58. Perillo, M.A.; Scarsdale, N.J.; Yu, R.K.; Maggio, B. Modulation by gangliosides of the lamellar-inverted micelle (hexagonal II) phase transition in mixtures containing phosphatidylethanolamine and dioleoylglycerol. Proc. Natl. Acad. Sci. USA, 1994, 91, 10019-10023.
59. Estella-Hermoso De Mendoza, A.; Campanero, M.A.; De la Iglesia-Vicente. J.; Gajate, C; Mollinedo, F.; Blanco-Prieto, M.J. Antitumor alkyl ether lipid edelfosine: Tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice. Clin. Cancer Res., 2009, 15, 858-864.
60. Hac-Wydro, K.; Dynarowicz-Latka, P. Effect of edelfosine on tumor and normal cells model membranes-A comparative study. Colloids Surf., B, 2010, 76, 366-369.
61. Hac-Wydro, K.; Dynarowicz-Latka, P.; Wydro, P.; Bak, K. Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way- the Langmuir monolayer study. Colloids Surf., B, 2011, 88, 635-640.
62. Flasihski, M; Wydro, P.; Hac-Wydro, K.; Dynarowicz-Latka, P. Cholesterol as a factor regulating the influence of natural (PAF and lysoPAF) vs. synthetic (ED) ether lipids on model lipid membranes. Biochim. Biophys. Acta - Biomembranes, 2013, 1828(11), 2700-2708.
63. Bernhard, H. Ganglioside GD3 shedding by human malignant melanoma cells. Int. J. Cancer, 1989, 44, 155-160.
64. Valentino, L.; Moss, T.; Olson, E.; Wang, H.J.; Elashoff, R.; Ladisch, S. Shed tumor gangliosides and progression of human neuroblastoma. Blood, 1990, 75, 1564-1567.
65. Hac-Wydro, K.; Dynarowicz-Latka, P. The relationship between the concentration of ganglioside GM1 and antitumor activity of edelfosine-The Langmuir monolayer study. Colloids Surf., B, 2010, 81, 385-388.
66. Van Blitterswijk, W.J.; De Veer, G.; Krol, J.H.; Emmelot, P. Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukemic GRSL cells. Biochim. Biophys. Acta, 1982, 688, 495-504.
67. Smyth, H.; Corrigan, A.; O'Kennedy, R. Lipid composition of human lymphocytes in patients with chronic lymphatic leukaemia with blocked T cell activity. Ir. J. Med. Sci., 1979, 148(11-12), 303-309.
68. Wydro, P.; Witkowska, K. The interactions between phosphatidylglycerols and phosphatidylethanolamines in model bacterial membranes. The effect of the acyl chain length and saturation. Colloids Surf., B, 2009, 72, 32-39.
69. Rakotomanga, M.; Saint-Pierre-Chazalet, M.; De Loiseau, P.M. Alteration of fatty acid and sterol metabolism in miltefosine-resistant leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrob. Agents Chemother., 2005, 49, 2677-2686.
70. Diomede, L.; Bizzi, A.; Magistrelli, A.; Modest, E.J.; Salmona, M.; Noseda, A. Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity. Int. J. Cancer, 1990, 46(2), 341-346.
71. Diomede, L.; Piovani, B.; Modest, E.J.; Noseda, A.; Salmona, M. Increased ether lipid cytotoxicity by reducing membrane cholesterol content. Int. J. Cancer, 1991, 49(3), 409-413.
72. Diomede, L.; Piovani, B.; Modest, E.J.; Salmona, M. The effect of culture medium composition on ether lipid cytotoxic activity. Lipids, 1993, 28(3), 189-192.
73. Ausili, A.; Torrecillas, A.; Aranda, F.J.; Mollinedo, F.; Gajate, C.; Corbalan-Garcia, S.; De Godos, A.; Gomez-Fernandez, J.C. Edelfosine is incorporated into rafts and alters their organization. J. Phys. Chem. B, 2008, 112, 11643-11654.
74. Mollinedo, F.; De la Iglesia-Vicente, J.; Gajate, C.; Estella-Hermoso De Mendoza, A.; Villa-Pulgarin, J.A.; Campanero, M.A.; Blanco-Prieto, M.J. Lipid raft-targeted therapy in multiple myeloma. Oncogene, 2010, 29(26) 3748-3757.
75. Mollinedo, F.; De la Iglesia-Vicente, J.; Gajate, C.; Estella-Hermoso De Mendoza, A.; Villa-Pulgarin, J.A.; de Frias, M.; Roué, G.; Gil, J.; Colomer, D.; Campanero, M.A.; Blanco-Prieto, M.J. In vitro and in vivo selective antitumor activity of edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin. Cancer, Res., 2010, 16(7) 2046-2054.
76. Heczkova, B.; Slotte, J.P. Effect of anti-tumor ether lipids on ordered domains in model membranes. FEBS Lett., 2006, 580, 2471-2476.
77. Van der Luit, A.H.; Budde, M.; Zerp, S.; Caan, W.; Klarenbeek, J.B.; Verheij, M.; Van Blitterswijk, W.J. Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin-and cholesterol-deficiency in lipid rafts. Biochem. J., 2007, 401, 541-549.
78. De Castro, S.L.; Santa-Rita, R.M.; Urbina, J.A. Croff, S.L. Antiprotozoal lysophospholipid analogs: A comparison of their activity against trypanosomatid parasites and tumour cells. Mini Rev. Med. Chem., 2004, 4, 139-148.
79. Croft, S.L.; Seifert, K.; Duchene, M. Antiprotozoal activities of phospholipid analogs. Mol. Biochem. Parasitol, 2003, 126, 165-172.
80. Azzouz, S.S.; Maache, M.; Garcia, G.R.; Osuna, A. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine. Basic Clin. Pharmacol. Toxicol, 2005, 96, 60-65.
81. Hac-Wydro, K.; Dynarowicz-Latka, P.; Zuk, R. Langmuir monolayer study toward combined antileishmanian therapy involving amphotericin B and edelfosine. J. Phys. Chem. B, 2009, 113, 14239-14246.
82. Kovarik, J.; Chabannes, D.; Borel, J.F. Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Int. J. Immunopharmacol., 1995, 17, 255-263.
83. Lucas, A.; Kim, Y.; Rivera-Pabon, O.; Chae, S.; Kim, D-H.; Kim, B. Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds. PLoS ONE, 2010, 5, e13121.